Jorge Nieva

Oncologist, scientist, teacher & learner

[Jorge Nieva @nievamd]

https://t.co/idZ6chjOq6

[Jorge Nieva @nievamd]

https://t.co/iP5Ob9QYvg

[Jorge Nieva @nievamd]

https://t.co/OXTI8EDCm6

[Mark @_MarkLeiser]

Thank you to @nievamd @uscnorris for sharing insights into fascinating #AACR26 data.

Could residue from pesticides be driving the 'hidden' #LungCancer epidemic among young nonsmokers?

Find out here 👇

[Jorge Nieva @nievamd]

Please join me on March 17th at the Lung Cancer Living Room where we will be discussing clinical trials. https://t.co/BmSrnyu1nC

[Jorge Nieva @nievamd]

https://t.co/ZgmfoYHQi6

[Oncology News Central @OncNewsCentral]

First-line #NSCLC care has evolved. In a conversation with @ADesaiMD (@ONealCancerUAB), @nievamd (@uscnorris) explains how patient priorities shape treatment intensification: https://t.co/40cb3B00IJ

#NSCLC #CancerCare

[Jorge Nieva @nievamd]

Great work by one of our outstanding graduate students. https://t.co/I0k8QR7mrN

[Jorge Nieva @nievamd]

Happy to see this important work on real world data of uncommon EGFR mutations publically available. https://t.co/dxgs43d59A

[Lung Cancers Today @Lung_Cancers]

🫁 As Lung Cancer Awareness Month continues, don't miss this insightful interview with @nievamd of @KeckMedicineUSC, who reflects on the importance of #LCAM, the cultural shift he's seen around lung cancer, and why screening is critical.

➡️ Watch: https://t.co/pH4yA8p4LH

#lcsm

[Jorge Nieva @nievamd]

https://t.co/6xzsBrek8c

[Jorge Nieva @nievamd]

Advancing new drugs to patients is important. But equally important is ensuring that drug toxicity is minimized. Very proud to have been part of this important study. https://t.co/d49EGH52EZ

[Jorge Nieva @nievamd]

My daughter has launched a sub stack project and is proving herself to be a terrific writer. I invite you all to read it and subscribe if you want to see more. https://t.co/FiJEJJmqsy

[Jorge Nieva @nievamd]

Very proud of Rahul Mudumba for completing this important pharmaco-economic analysis of ALK fusion lung cancer treatment. https://t.co/JO4r6knBX9

[Lung Cancers Today @Lung_Cancers]

💊 How do steroids impact survival in patients undergoing immunotherapy for NSCLC?

🫁 Don't miss this insightful interview with @nievamd of @KeckMedicineUSC, who discusses recent bedside-to-bench research that addressed the question.

➡️ Watch: https://t.co/UERGUIbCtO

#lcsm

[Jorge Nieva @nievamd]

https://t.co/a3eOXPc0NB

[Fred R. Hirsch @fred_hirsch]

Greetings from Huntington Beach, CA.

[Fawzi Abu Rous, MD @FawziAbuRous]

Diving beyond EGFR in NSCLC with an excellent session chaired by @SchenkLab, featuring a stellar lineup of talks on KRAS, BRAF, ROS1, MET, RET, and more!

With insights from @christinemphmd @drgandara @mihaela_aldea @nievamd @riess_md
@OncLive #BTGLung2025 #LCSM #Oncology

[OncLive.com @OncLive]

A huge thanks to @nievamd, of @KECKSchool_USC, who stopped by during #BTGLung2025 to talk about the management of ALK rearrangements in NSCLC! Check out our site for exclusive insights from Dr Nieva and more! #lcsm #oncology
https://t.co/1a5dzPxT5l

[Eric K. Singhi, MD @lungoncdoc]

‼️Polling Q2. Emerging treatment options in SCLC

What do you see as the most promising strategy to improve OS in SCLC?

#BTGLung2025 @sands_jacob @triparnasen @NarjustFlorezMD @DrEdKim @AnaVManana @OncLive